Clinical Trial Update: Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial update reports safety findings for intravenous lacosamide followed by twice-daily oral lacosamide in adults with partial-onset seizures. Results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Vimpat (lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Partial Epilepsies, Partial Onset Seizures | Phase 3 | Status: COMPLETED | Results posted: 2010-10-20